Literature DB >> 25260878

Computational modeling of pathophysiologic responses to exercise in Fontan patients.

Ethan Kung1, James C Perry, Christopher Davis, Francesco Migliavacca, Giancarlo Pennati, Alessandro Giardini, Tain-Yen Hsia, Alison Marsden.   

Abstract

Reduced exercise capacity is nearly universal among Fontan patients. Although many factors have emerged as possible contributors, the degree to which each impacts the overall hemodynamics is largely unknown. Computational modeling provides a means to test hypotheses of causes of exercise intolerance via precisely controlled virtual experiments and measurements. We quantified the physiological impacts of commonly encountered, clinically relevant dysfunctions introduced to the exercising Fontan system via a previously developed lumped-parameter model of Fontan exercise. Elevated pulmonary arterial pressure was observed in all cases of dysfunction, correlated with lowered cardiac output (CO), and often mediated by elevated atrial pressure. Pulmonary vascular resistance was not the most significant factor affecting exercise performance as measured by CO. In the absence of other dysfunctions, atrioventricular valve insufficiency alone had significant physiological impact, especially under exercise demands. The impact of isolated dysfunctions can be linearly summed to approximate the combined impact of several dysfunctions occurring in the same system. A single dominant cause of exercise intolerance was not identified, though several hypothesized dysfunctions each led to variable decreases in performance. Computational predictions of performance improvement associated with various interventions should be weighed against procedural risks and potential complications, contributing to improvements in routine patient management protocol.

Entities:  

Mesh:

Year:  2014        PMID: 25260878      PMCID: PMC4376649          DOI: 10.1007/s10439-014-1131-4

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  38 in total

1.  Ventricular performance before and after Fontan repair for univentricular atrioventricular connection: angiographic and radionuclide assessment.

Authors:  T Akagi; L N Benson; M Green; J Ash; D L Gilday; W G Williams; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1992-10       Impact factor: 24.094

2.  Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting.

Authors:  Jacob N Schroder; Matthew L Williams; Jonathan A Hata; Lawrence H Muhlbaier; Madhav Swaminathan; Joseph P Mathew; Donald D Glower; Christopher M O'Connor; Peter K Smith; Carmelo A Milano
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

3.  Exercise responses in patients with congenital heart disease after Fontan repair: patterns and determinants of performance.

Authors:  M H Gewillig; U R Lundström; C Bull; R K Wyse; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1990-05       Impact factor: 24.094

4.  Single-beat estimation of end-systolic pressure-volume relation in humans. A new method with the potential for noninvasive application.

Authors:  H Senzaki; C H Chen; D A Kass
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

5.  Effect of intrathoracic pressure on left ventricular performance.

Authors:  A J Buda; M R Pinsky; N B Ingels; G T Daughters; E B Stinson; E L Alderman
Journal:  N Engl J Med       Date:  1979-08-30       Impact factor: 91.245

6.  Alterations in left ventricular volumes induced by Valsalva manoeuvre.

Authors:  J Z Brooker; E L Alderman; D C Harrison
Journal:  Br Heart J       Date:  1974-07

7.  Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle.

Authors:  D J Driscoll; G K Danielson; F J Puga; H V Schaff; C T Heise; B A Staats
Journal:  J Am Coll Cardiol       Date:  1986-05       Impact factor: 24.094

8.  Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators.

Authors:  G A Lamas; G F Mitchell; G C Flaker; S C Smith; B J Gersh; L Basta; L Moyé; E Braunwald; M A Pfeffer
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

Review 9.  Distensibility of the normal human lung circulation during exercise.

Authors:  John T Reeves; John H Linehan; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-03       Impact factor: 5.464

10.  Cardiorespiratory response to exercise after modified Fontan operation: determinants of performance.

Authors:  K Durongpisitkul; D J Driscoll; D W Mahoney; P C Wollan; C D Mottram; F J Puga; G K Danielson
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

View more
  4 in total

1.  Using a Novel In Vitro Fontan Model and Condition-Specific Real-Time MRI Data to Examine Hemodynamic Effects of Respiration and Exercise.

Authors:  Michael Tree; Zhenglun Alan Wei; Phillip M Trusty; Vrishank Raghav; Mark Fogel; Kevin Maher; Ajit Yoganathan
Journal:  Ann Biomed Eng       Date:  2017-10-24       Impact factor: 3.934

2.  Effect of respiration on cardiac filling at rest and during exercise in Fontan patients: A clinical and computational modeling study.

Authors:  Alexander Van De Bruaene; Guido Claessen; Andre La Gerche; Ethan Kung; Alison Marsden; Pieter De Meester; Sarah Devroe; Jan Bogaert; Piet Claus; Hein Heidbuchel; Werner Budts; Marc Gewillig
Journal:  Int J Cardiol Heart Vasc       Date:  2015-08-13

3.  Engineering Perspective on Cardiovascular Simulations of Fontan Hemodynamics: Where Do We Stand with a Look Towards Clinical Application.

Authors:  Zhenglun Alan Wei; Mark A Fogel
Journal:  Cardiovasc Eng Technol       Date:  2021-06-10       Impact factor: 2.495

4.  Dobutamine stress testing in patients with Fontan circulation augmented by biomechanical modeling.

Authors:  Bram Ruijsink; Konrad Zugaj; James Wong; Kuberan Pushparajah; Tarique Hussain; Philippe Moireau; Reza Razavi; Dominique Chapelle; Radomír Chabiniok
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.